missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Imatinib, MedChemExpress
Description
Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.
Specifications
Specifications
| Chemical Name or Material | Imatinib |
| Physical Form | Solid |
| CAS | 152459-95-5 |
| Color | Light Yellow |
| Quantity | 1 g |
| Purity Grade Notes | Research |
| Molecular Formula | C29H31N7O |
| For Use With (Application) | Cancer-Kinase/protease |
| Synonym | STI571 CGP-57148B |
| Solubility Information | DMSO : 12.5 mg/mL (25.32 mM; Need ultrasonic) ∣H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?